Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -77.06% is 33% below its 5-year average of -57.96%, around the middle of its 5-year range (-116.51%–-27.47%).
As of the fiscal period ended Tuesday, June 30, 2026. 23.91% below its 12-month average of -62.19%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q4 FY2026 (2026-06-30): -77.06%.
RETURN ON EQUITY (ROE)
-77.06%
RETURN ON EQUITY (ROE) AVG TTM
-62.19%
RETURN ON EQUITY (ROE) AVG 3Y
-63.98%
RETURN ON EQUITY (ROE) AVG 5Y
-57.96%
RETURN ON EQUITY (ROE) AVG 10Y
-107.97%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-23.91%
CURRENT VS 3Y AVG
-20.45%
CURRENT VS 5Y AVG
-32.95%
CURRENT VS 10Y AVG
+28.63%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-83.42%
vs the sector median at left
Rezolute, Inc.
Market Cap
$407.87M
Return on Equity (ROE)
-77.06%
TTM Avg
-62.19%
3Y Avg
-63.98%
5Y Avg
-57.96%
Market Cap
$407.95M
Return on Equity (ROE)
-51.17%
TTM Avg
-29.16%
3Y Avg
-33.45%
5Y Avg
-16.04%
Market Cap
$406.13M
Return on Equity (ROE)
-37.05%
TTM Avg
-58.80%
3Y Avg
-40.96%
5Y Avg
-32.01%
Market Cap
$404.81M
Return on Equity (ROE)
-28.18%
TTM Avg
-0.06%
3Y Avg
10.58%
5Y Avg
10.58%
Market Cap
$404.44M
Return on Equity (ROE)
-80.96%
TTM Avg
-47.93%
3Y Avg
-34.61%
5Y Avg
-20.56%
Market Cap
$411.43M
Return on Equity (ROE)
14.40%
TTM Avg
1.26%
3Y Avg
-7.83%
5Y Avg
-9.02%
Market Cap
$404.24M
Return on Equity (ROE)
-43.14%
TTM Avg
2.19%
3Y Avg
15.11%
5Y Avg
15.11%
Market Cap
$413.71M
Return on Equity (ROE)
-69.06%
TTM Avg
36.89%
3Y Avg
36.89%
5Y Avg
36.89%
Market Cap
$415.22M
Return on Equity (ROE)
-121.12%
TTM Avg
180.84%
3Y Avg
-1331.02%
5Y Avg
-839.91%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rezolute, Inc. (RZLT) | $407.87M | -77.06% | -62.19% | -63.98% | -57.96% |
| Neurogene Inc. (NGNE)vs › | $407.95M | -51.17% | -29.16% | -33.45% | -16.04% |
| Myriad Genetics, Inc. (MYGN)vs › | $406.13M | -37.05% | -58.80% | -40.96% | -32.01% |
| Shoulder Innovations, Inc. (SI)vs › | $404.81M | -28.18% | -0.06% | 10.58% | 10.58% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $404.44M | -80.96% | -47.93% | -34.61% | -20.56% |
| Strata Critical Medical, Inc. (SRTA)vs › | $411.43M | 14.40% | 1.26% | -7.83% | -9.02% |
| Carlsmed, Inc. (CARL)vs › | $404.24M | -43.14% | 2.19% | 15.11% | 15.11% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $413.71M | -69.06% | 36.89% | 36.89% | 36.89% |
| Senseonics Holdings, Inc. (SENS)vs › | $415.22M | -121.12% | 180.84% | -1331.02% | -839.91% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $415.88M | -65.99% | -51.25% | -81.12% | -81.12% |
ROE
-77.1%
ROA
-68.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -77.06% |
| 2026-03-31 | -69.74% |
| 2025-12-31 | -65.80% |
| 2025-09-30 | -52.45% |
| 2025-06-30 | -45.90% |
| 2025-03-31 | -88.41% |
| 2024-12-31 | -71.43% |
| 2024-09-30 | -61.10% |
| 2024-06-30 | -56.58% |
| 2024-03-31 | -82.15% |
| 2023-12-31 | -61.96% |
| 2023-09-30 | -54.54% |
| 2023-06-30 | -44.58% |
| 2023-03-31 | -38.08% |
| 2022-12-31 | -31.16% |
| 2022-09-30 | -28.12% |
| 2022-06-30 | -27.47% |
| 2022-03-31 | -73.45% |
| 2021-12-31 | -49.17% |
| 2021-09-30 | -116.51% |
| 2021-06-30 | -80.09% |
| 2021-03-31 | -61.65% |
| 2020-12-31 | -53.79% |
| 2020-09-30 | -430.69% |
| 2020-06-30 | -276.08% |
| 2020-03-31 | -193.03% |
| 2019-12-31 | -236.01% |
| 2019-09-30 | -155.98% |
| 2019-03-31 | -855.77% |
| 2017-12-31 | -630.66% |
| 2017-09-30 | -296.52% |
| 2017-06-30 | -237.77% |
| 2017-03-31 | -212.28% |
| 2016-12-31 | -205.29% |
| 2016-09-30 | -188.53% |
| 2016-06-30 | -170.25% |
| 2015-12-31 | -359.09% |
| 2015-09-30 | -184.02% |
| 2015-06-30 | -125.50% |
| 2015-03-31 | -106.43% |
| 2014-12-31 | -156.61% |
| 2014-09-30 | -221.67% |
| 2014-06-30 | -151.88% |
| 2014-03-31 | -256.91% |
